What is Nectar Lifesciences Price-to-Operating-Cash-Flow?
As of today (2024-05-19), Nectar Lifesciences's share price is $0.408.
Nectar Lifesciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00. Hence, Nectar Lifesciences's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Nectar Lifesciences's Price-to-Operating-Cash-Flow or its related term are showing as below:
LUX:NECLF'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0 Med: 4.1 Max: 38.84
Current: 3.41
During the past 13 years, Nectar Lifesciences's highest Price-to-Operating-Cash-Flow Ratio was 38.84. The lowest was 0.00. And the median was 4.10.
Nectar Lifesciences's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was $0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Nectar Lifesciences was 65.80% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 118.20% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -3.20% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -5.10% per year.
During the past 13 years, Nectar Lifesciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 134.50% per year. The lowest was -35.20% per year. And the median was -4.30% per year.
Nectar Lifesciences Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Nectar Lifesciences's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nectar Lifesciences Price-to-Operating-Cash-Flow Chart
|
Nectar Lifesciences Annual Data
|
|
Trend |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
0.78 |
19.52 |
5.68 |
2.66 |
3.04 |
|
Nectar Lifesciences Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
2.66 |
- |
- |
- |
3.04 |
Competitive Comparison of Nectar Lifesciences's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Nectar Lifesciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nectar Lifesciences's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nectar Lifesciences's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Nectar Lifesciences's Price-to-Operating-Cash-Flow falls into.
Nectar Lifesciences Price-to-Operating-Cash-Flow Calculation
Nectar Lifesciences's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 0.408 | / | 0 |
| = | |
Nectar Lifesciences's Share Price of today is $0.408.
Nectar Lifesciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Nectar Lifesciences (LUX:NECLF) Business Description
Traded in Other Exchanges
Address
SCO 38-39, Sector 9d, B-1011/1012, 10th Floor NAURANG HOUSE, Chandigarh, IND, 160009
Nectar Lifesciences Ltd is an India-based pharmaceutical company. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products, The company's product includes cefixime trihydrate, cefdinir, cefprozil, cefoxitin sodium, cefpirome sulphate, and others. Geographically, it derives a majority of its revenue from India.
Nectar Lifesciences (LUX:NECLF) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LUX:NECLF has been successfully added to your